Literature DB >> 11964958

Increased rectal nitric oxide in children with active inflammatory bowel disease.

Tryggve Ljung1, Eva Beijer, Max Herulf, Eddie Weitzberg, Jon O N Lundberg, Yigael Finkel, Per M Hellström.   

Abstract

BACKGROUND: Luminal nitric oxide increases in ulcerative colitis and Crohn disease. The authors have previously used a minimally invasive method to demonstrate increased luminal nitric oxide in ulcerative colitis and Crohn disease of the colon. The aim of the current study was to determine whether this method could be applied to identify inflammatory activity in ulcerative colitis and Crohn disease in children.
METHODS: Thirty-six children (18 of whom had active disease) with inflammatory bowel disease localized to the colon were studied. The control group comprised 12 healthy children. To measure nitric oxide, a silicon catheter with an inflatable balloon was inserted into the rectum and inflated with 10 mL of nitric oxide-free air. After a 10-minute incubation time, the air was withdrawn and nitric oxide concentrations were immediately analyzed using a chemiluminescence technique.
RESULTS: Children with active ulcerative colitis and Crohn disease of the colon had greatly increased luminal nitric oxide concentrations in the rectum (8,840 +/- 5,120 and 15,170 +/- 4,757 parts per billion [ppb], respectively) compared with controls (77 +/- 17 ppb) (P < 0.001). Children with nonactive ulcerative colitis or Crohn disease displayed low concentrations of rectal nitric oxide (356 +/- 110 and 188 +/- 55 ppb, respectively), which was not different from that of healthy controls.
CONCLUSION: Rectal nitric oxide measurement is a feasible and useful method for monitoring disease activity in inflammatory bowel disease, especially in children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964958     DOI: 10.1097/00005176-200203000-00016

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Measurement of Fractional Exhaled Nitric Oxide as a Marker of Disease Activity in Inflammatory Bowel Disease.

Authors:  Erkanda Ikonomi; Robin D Rothstein; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2016-01-27

2.  Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases.

Authors:  Golshid Jahanshahi; Vian Motavasel; Ali Rezaie; Ali A Hashtroudi; Naser E Daryani; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.487

3.  Pegylated arginine deiminase downregulates colitis in murine models.

Authors:  Helieh S Oz; Jian Zhong; Willem J S de Villiers
Journal:  Mediators Inflamm       Date:  2012-01-17       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.